Shares of Waaree Energies Limited fell as much as 5.55% on Monday, June 29, 2026, closing at ₹2,842.50 on the BSE — a decline that came despite, and in some analyst readings partly because of, a company clarification statement specifically intended to reassure investors. The stock had already slipped over 6% across the preceding five trading sessions and 8.1% over the past month, even as it remains up modestly for the 2026 calendar year. At Monday’s close, India’s largest solar module manufacturer carried a market capitalisation of approximately ₹82,734 crore and traded at a price-to-earnings ratio of 22.29 times.
The proximate cause was a final determination issued by US Customs and Border Protection on June 23, 2026, in a long-running trade enforcement investigation — and the unusual dynamic of a company issuing a Saturday clarification statement that, rather than calming the market, appeared to draw closer attention to a story investors might otherwise have allowed to fade.
What the CBP Actually Determined
The investigation originated in 2025, when a coalition of American solar manufacturers — operating through the American Alliance for Solar Manufacturing Trade Committee — filed a complaint alleging that Waaree had been circumventing the anti-dumping and countervailing duties (AD/CVD) the United States imposes on solar cells and modules from China, Vietnam, Malaysia, and other countries identified as sources of dumped or subsidised solar product. The Committee’s complaint pointed to specific data: Waaree had dramatically increased its imports of solar cells from China into India during the relevant period, had imported more than 5.4 million kilograms of crystalline silicon photovoltaic modules into the US in 2024 alone, and that broader US imports of CSPV modules from India had surged more than 2,250% between 2021 and 2023 — a spike that coincided suspiciously with a decline in direct imports from China as AD/CVD enforcement tightened. CBP launched a formal investigation under the Enforce and Protect Act (EAPA) in response.
The final determination, issued June 23, 2026, found that Waaree had indeed evaded AD/CVD orders specifically with respect to solar cells sourced from Vietnam and Malaysia between 2021 and June 2026. Victoria Cho, director of the enforcement operations division of the Trade Remedy Law Enforcement Directorate within the US Office of Trade, wrote in the notice that “substantial evidence on the record of this investigation indicates that Waaree entered covered merchandise through evasion, resulting in the avoidance of applicable AD/CVD deposits or other security.” As a consequence, CBP will require cash deposits for anti-dumping tariffs of up to 271.28% on the specific solar modules and cells found to be subject to evasion — covering imports made over the nearly five-year period under review. CBP said it would continue to suspend liquidation of the duties owed until either a final tariff bill is settled or any Waaree appeal is resolved.
Critically, and this is the detail underlying Waaree’s clarification statement, CBP explicitly declined the petitioning Committee’s request to apply “adverse inferences” — a legal mechanism that would have resulted in a blanket evasion finding covering the entirety of Waaree’s US-bound shipments. Instead, the determination is narrowly scoped: it applies only to the specific historical import entries linked to Vietnam- and Malaysia-sourced cells found to have circumvented the relevant duty orders, not to Waaree’s broader US business. Tim Brightbill, lead attorney for the petitioning Committee, characterised the outcome as a partial win for the industry’s enforcement push, commending “Customs for its rigorous review of the record and its commitment to upholding the integrity of our trade remedy laws.”
The Company’s Clarification and Why It May Have Backfired
Waaree’s own statement, issued on Sunday, June 28 — five days after the determination itself — emphasised what the company considers the most important finding: that CBP confirmed, following a detailed investigation including an on-site verification of Waaree’s Indian manufacturing facility, that the company did not export solar modules manufactured using Chinese-origin solar cells to the United States. The company stressed that the determination “is limited to a narrow subset of certain historical import entries” and that its US business “continues to operate normally,” with no impact on ongoing manufacturing, customer deliveries, or commercial operations. Waaree noted that CBP confirmed the company had fully cooperated throughout the investigation, drew no adverse inference, and declined to make the broader evasion finding the petitioners had sought.
Read in isolation, that is a substantially favourable outcome relative to the worst-case scenario the original complaint sought — a blanket finding that would have applied steep tariffs across Waaree’s entire US import history rather than a narrow historical subset. The market’s response, however, suggests investors are weighing a different set of facts. TradeBrains’ analysis captured the dynamic precisely: “When a company files a media statement on a Saturday to clarify a regulatory matter, the market tends to take notice — and not always kindly.” The unusual timing of a weekend clarification, arriving five days after the underlying CBP order rather than alongside it, read to some market participants as reactive rather than proactive disclosure — a sequence that tends to generate more scrutiny of the underlying facts than a same-day, comprehensive disclosure would have.
The substance of what remains unresolved is also material. Even accepting Waaree’s framing that the finding is narrow, a finding of evasion is still a finding of evasion. The company has confirmed it is evaluating a de novo administrative review and potential judicial proceedings before the US Court of International Trade — a process that could extend over many months, during which the regulatory and reputational overhang persists even if the day-to-day commercial impact remains genuinely limited, as the company contends.
What a Domestic Brokerage Is Actually Watching
A domestic brokerage’s note on the determination — cited by Business Standard without being identified by name — offered the most granular framing of the actual risk involved, and is worth examining closely because it represents the institutional read on a story that retail sentiment has reacted to more sharply.
The brokerage flagged that CBP’s specific observation of a “four-year history of reporting the wrong country of origin” carries reputational risk that could weigh on Waaree’s standing with US customers and could, in a worst case, affect a meaningful portion of the company’s approximately ₹53,000 crore order book — a number large enough that even a modest percentage impact would be financially material. However, the same note concluded that the downside from here appears limited, for three specific reasons: CBP confirmed that Waaree had sufficient non-Chinese solar cell production capacity to legitimately support its US shipment volumes (undermining the most severe version of the circumvention narrative); CBP did not apply the blanket adverse-inference ruling that would have implicated the company’s entire US import history; and the finding was restricted specifically to certain historical import entries tied to Vietnam and Malaysia rather than extending across the full breadth of Waaree’s supply chain.
On the strength of that assessment, the brokerage retained its “Add” rating on the stock with a target price of ₹3,185 — implying upside of approximately 12% from Monday’s closing price of ₹2,842.50. The brokerage identified three specific monitorables going forward: the ultimate quantum of any retrospective duties assessed once the suspended liquidation is resolved, the outcome of Waaree’s administrative or judicial appeal process, and any spillover risk from a separate, still-pending anti-dumping and countervailing duty proceeding.
That separate proceeding is itself significant context. Independent of the EAPA circumvention finding, the US Department of Commerce has issued a preliminary anti-dumping determination imposing duties of 123.04% on solar imports from India, Indonesia, and Laos as a category — a determination that applies to non-circumventing Waaree products and reflects a broader US trade policy posture toward Indian-origin solar manufacturing that exists independently of the company-specific evasion finding. Investors evaluating Waaree’s US exposure need to separate these two distinct and overlapping regulatory threads: the company-specific EAPA evasion finding (narrow, historical, partially resolved) and the broader, ongoing AD/CVD proceeding against Indian-origin solar products as a category (wider in scope, still preliminary, and not specific to any finding of wrongdoing by Waaree).
The Financial Backdrop: A Genuinely Strong Quarter
The regulatory overhang needs to be weighed against operating performance that, on its own terms, was exceptionally strong. Waaree Energies reported consolidated net profit of ₹1,061.10 crore for Q4 FY26, up 71.4% year-on-year from ₹618.91 crore in the same quarter the previous year. Revenue from operations for the quarter ended March 31, 2026, surged 111.8% year-on-year to ₹8,480.25 crore. This is the financial performance of a company executing well on the fundamental demand tailwind for solar manufacturing capacity — both domestically, where India’s renewable energy buildout continues to accelerate, and in export markets, where US demand for non-Chinese-origin solar product remains structurally robust even as the regulatory environment around country-of-origin verification has tightened.
The combination of these two facts — a regulatory finding that introduces genuine but bounded uncertainty, and an underlying business performing at a rate that more than doubled year-on-year profit — is precisely the tension the stock’s price action is attempting to resolve. A 5% single-day decline, and a roughly 8% one-month decline, on a stock trading at 22.29 times earnings with year-on-year profit growth above 70%, suggests the market is pricing meaningful regulatory risk premium into the stock without abandoning the underlying growth thesis entirely.
The Decision Framework for Investors
Three distinct questions determine whether the post-determination price represents an attractive entry point or a value trap, and each deserves separate consideration rather than being collapsed into a single buy-or-sell verdict.
The first is the financial quantum question: how large will the actual retrospective duty bill be once CBP’s suspended liquidation is finally resolved? The 271.28% tariff rate applies only to the specific historical entries found to have evaded the Vietnam and Malaysia duty orders — not to Waaree’s total US revenue or even to its total US import volume. Until the precise dollar value of the affected historical shipments is disclosed, either by the company or through the CBP’s own enforcement proceedings, investors are working with a maximum tariff rate but an unknown base, which makes the absolute financial exposure genuinely difficult to quantify from public information alone.
The second is the appeal-outcome question. Waaree’s stated intention to pursue a de novo administrative review and potential US Court of International Trade litigation introduces a multi-month to multi-year timeline during which the issue remains technically unresolved, even if commercially contained. Trade remedy litigation of this kind in US courts has a mixed record for respondent companies, and the strength of Waaree’s underlying factual position — including the CBP’s own finding of sufficient legitimate non-Chinese cell production capacity — will determine whether the appeal meaningfully reduces the eventual exposure.
The third is the order book and reputational question, which is the most qualitative and arguably the most important for medium-term investors. If US customers — module buyers, project developers, and utility-scale procurement teams — treat the CBP finding as disqualifying or materially risk-increasing, the ₹53,000 crore order book could see slower conversion, renegotiation, or in a worst case, cancellation risk on the subset of orders most exposed to US delivery. If, conversely, customers accept the company’s framing — that this was a narrow historical issue now resolved with no ongoing impact, validated by CBP’s own finding that current operations are unaffected — the order book should convert largely as planned, and the stock’s current weakness becomes a buying opportunity precisely because the market has priced in more reputational damage than the facts ultimately support.
For investors who share the cited brokerage’s assessment — that the finding is narrow, the company’s non-circumventing capacity was independently verified, and the order book impact is likely to be contained — the ₹3,185 target and the current ₹2,842.50 price represent a reasonable risk-adjusted entry point, particularly against a Q4 profit growth rate of 71.4%. For investors who weight the unresolved appeal timeline, the four-year pattern of country-of-origin reporting issues CBP specifically flagged, and the separate, broader 123.04% preliminary AD/CVD determination against Indian-origin solar products as a category more heavily, the prudent course is to wait for the appeal process and the retrospective duty quantum to clarify before committing fresh capital, even at the currently discounted price.
Disclaimer: Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. The securities quoted are exemplary and are not recommendatory.
